Identification of a novel functional 85-kD glycoprotein restricted to long-term dividing human lymphocytic lines.

[1]  L. Boumsell,et al.  The CD39 molecule defines distinct cytotoxic subsets within alloactivated human CD8‐positive cells , 1992, European journal of immunology.

[2]  G. Freeman,et al.  Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells , 1992, The Journal of experimental medicine.

[3]  L. Boumsell,et al.  Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. , 1992, Journal of immunology.

[4]  W. Hahn,et al.  CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1 , 1991, Nature.

[5]  B. Seed,et al.  The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. , 1991, Journal of immunology.

[6]  D. Sgroi,et al.  The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and α2–6 sialyltransferase, CD75, on B cells , 1991, Cell.

[7]  E. Ciccone,et al.  A Novel surface molecule expressed by long‐term cultured T and natural killer cells is involved in cell activation , 1991, European journal of immunology.

[8]  C. Morimoto,et al.  The 1A4 molecule (CD27) is involved in T cell activation. , 1991, Journal of immunology.

[9]  G. Leca,et al.  Proliferation of resting lymphocytes is induced by triggering T cells through an epitope common to the three CD18/CD11 leukocyte adhesion molecules. , 1991, Cellular immunology.

[10]  H. Velde,et al.  The B-cell surface protein CD72/Lyb-2 is the ligand for CDS , 1991, Nature.

[11]  F. Spertini,et al.  Induction of human T cell proliferation by a monoclonal antibody to CD5. , 1991, Journal of immunology.

[12]  G. Leca,et al.  Selective induction of autocytotoxic activity through the CD3 molecule , 1990, European journal of immunology.

[13]  G. Leca,et al.  Immunodeficiency after Bone Marrow Transplantation can be associated with Autoreactive T‐Cell Receptor γω‐bearing Lymphocytes , 1990, Immunological reviews.

[14]  H. Yakura,et al.  A novel homodimeric molecule involved in human T cell activation. , 1990, Journal of Immunology.

[15]  A. Freedman,et al.  Expression of the human leukocyte adhesion molecule, LAM1. Identity with the TQ1 and Leu-8 differentiation antigens. , 1990, Journal of immunology.

[16]  G. Leca,et al.  Identification of a novel 110-kilodalton structure expressed on a subset of T cell receptor-gamma delta-bearing cloned lymphocytes. , 1990, Journal of Immunology.

[17]  Michael L. Dustin,et al.  T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1 , 1989, Nature.

[18]  S. Meuer,et al.  Triggering of the alternative pathway of human T cell activation involves members of the T 200 family of glycoproteins , 1989, European journal of immunology.

[19]  H. Masutani,et al.  Mitogenicity and down-regulation of high-affinity interleukin 2 receptor by YTA-1 and YTA-2, monoclonal antibodies that recognize 75-kDa molecules on human large granular lymphocytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[20]  N. Tonks,et al.  CD45 regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T or B cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[21]  F. Sigaux,et al.  Prominent expansion of circulating lymphocytes bearing gamma T-cell receptors, with preferential expression of variable gamma genes after allogeneic bone marrow transplantation. , 1988, Blood.

[22]  F. Sigaux,et al.  Expression of the T Cell Gamma Gene by a Functionally Defined Human T Cell Clone Characterization at DNA, RNA, and Cell Membrane Level , 1988, Scandinavian journal of immunology.

[23]  K. Smith.  The interleukin 2 receptor. , 1988, Advances in immunology.

[24]  M. Hemler,et al.  Adhesive protein receptors on hematopoietic cells. , 1988, Immunology today.

[25]  B. Bierer,et al.  Sialophorin, a surface sialoglycoprotein defective in the Wiskott- Aldrich syndrome, is involved in human T lymphocyte proliferation , 1987, The Journal of experimental medicine.

[26]  B. Fleischer.  A novel pathway of human T cell activation via a 103 kD T cell activation antigen. , 1987, Journal of immunology.

[27]  P. Rabinovitch,et al.  Crosslinking of surface antigens causes mobilization of intracellular ionized calcium in T lymphocytes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Kato,et al.  Interleukin 2 high-affinity receptor expression requires two distinct binding proteins , 1987, The Journal of experimental medicine.

[29]  N. Letvin,et al.  The role of the 2H4 molecule in the generation of suppressor function in Con A-activated T cells. , 1986, Journal of immunology.

[30]  M. Amiot,et al.  The Human Cell Surface Glycoprotein Complex (gp 120,200) Recognized by Monoclonal Antibody K20 is a Component Binding to Phytohaemagglutinin on T Cells , 1986, Scandinavian journal of immunology.

[31]  G. Pantaleo,et al.  Involvement of T44 molecules in an antigen-independent pathway of T cell activation. Analysis of the correlations to the T cell antigen- receptor complex , 1985, The Journal of experimental medicine.

[32]  N. Letvin,et al.  The isolation and characterization of the human helper inducer T cell subset. , 1985, Journal of immunology.

[33]  S. Fu,et al.  Human T cell activation. I. Monocyte-independent activation and proliferation induced by anti-T3 monoclonal antibodies in the presence of tumor promoter 12-o-tetradecanoyl phorbol-13 acetate , 1985, The Journal of experimental medicine.

[34]  T. Honjo,et al.  TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). , 1985, Journal of immunology.

[35]  E. Reinherz,et al.  Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. , 1984, Journal of immunology.

[36]  T. Flotte,et al.  Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines. , 1984, Journal of immunology.

[37]  E. Reinherz,et al.  An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein , 1984, Cell.

[38]  J. Strominger,et al.  Characterization of a novel differentiation antigen complex recognize by a monoclonal antibody (A-1A5): unique activation-specific molecular forms on stimulated T cells. , 1983, Journal of immunology.

[39]  O. Martínez-Maza,et al.  Is the E receptor on human T lymphocytes a "negative signal receptor"? , 1982, Journal of immunology.

[40]  A. Bernard,et al.  Phenomenon of human T cells rosetting with sheep erythrocytes analyzed with monoclonal antibodies. “Modulation” of a partially hidden epitope determining the conditions of interaction between T cells and erythrocytes , 1982, The Journal of experimental medicine.

[41]  F. Lopez,et al.  Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[42]  T. Waldmann,et al.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. , 1981, Journal of immunology.

[43]  J. Dausset,et al.  An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells. Distribution on normal and malignant lymphoid cells , 1980, The Journal of experimental medicine.